Figure 5.
(a) OCT image of a premature infant with type 1 ROP (zone 2 stage 3 with plus disease) before intravitreal ranibizumab treatment and (b) two months after intravitreal ranibizumab treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.